Philips buys into economy heart X-ray market with Alpha X-Ray purchase
This article was originally published in Clinica
Medtech giant Philips is set to purchase Indian cardiovascular firm Alpha X-Ray Technologies for an undisclosed fee. The Dutch group will benefit from Alpha’s presence in the budget segment of the market for cardiovascular X-ray systems. This segment is said to be expanding the quickest, with annual growth rates expected to reach 10-15% in the coming years, said Philips. This deal, anticipated to close in the fourth quarter of 2008, is part of the company’s drive to invest in emerging markets – earlier this year the Amsterdam, the Netherlands-based firm bought Brazilian healthcare manufacturer Dixtal Biomedica e Tecnologia (see Clinica No 1307, p 17) and Chinese patient monitoring company Shenzhen Goldway Industrial (see Clinica No 1302, p 15).
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals